Clinical impact of a PCR assay for rapid identification of Klebsiella pneumoniae in blood cultures

Journal of Clinical Microbiology

Volumn 46, Issue 1, 2008, Pages 377-379

  Neuberger, A ^a   Oren, I ^b   Sprecher, H ^c,d  

^a Rambam Health Care Campus ^*  (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Microbiology Laboratory   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; BLOOD; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; TIME FACTORS;

KLEBSIELLA PNEUMONIAE;

EID: 38149019034     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00568-07     Document Type: Article

References (15)

1. Bishara, J., G. Livne, S. Ashkenazi, I. Levy, S. Pitlik, O. Ofir, and B. Lev. 2005. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Isr. Med. Assoc. J. 7:298-301.
2. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
3. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Approved standard. CLSI M100-S16. CLSI, Wayne, PA.
4. Harbarth, S., J. Garbino, J. Pugin, J. A. Romand, D. Lew, and D. Pittet. 2003. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am. J. Med. 115:529-535.
5. Ibrahim, E. H., G. Sherman, S. Ward, V. J. Fraser, and M. H. Kollef. 2000. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146-155.
6. Jones, R. N., and M. A. Pfaller. 2003. Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum β-lactamase in Europe. Clin. Microbiol. Infect. 9:708-712.
7. Lautenbach, E., B. L. Strom, W. B. Bilker, J. B. Patel, P. H. Edelstein, and N. O. Fishman. 2001. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 33:1288-1294.
8. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546-1554.
9. Paterson, D. L., W. C. Ko, A. V. Gottberg, S. Mohapatra, J. M. Casellas, H. Goossens, L. Mulazimoglu, G. Trenholme, K. P. Klugman, R. A. Bonomo, L. B. Rice, M. M. Wagner, J. G. McCormack, and V. L. Yu. 2004. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin. Infect. Dis. 39:31-37.
10. Peters, R. P. H., P. H. M. Savelkoul, A. M. Simoons-Smit, S. A. Danner, C. M. J. E. Vandenbroucke-Grauls, and M. A. van Agtmael. 2006. Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice. J. Clin. Microbiol. 44:119-123.
11. Peters, R. P. H., M. A. van Agtmael, S. A. Danner, P. H. M. Savelkoul, and C. M. J. E. Vandenbroucke-Grauls. 2004. New developments in the diagnosis of bloodstream infections. Lancet Infect. Dis. 4:751-760.
12. Pfaller, M. A., and J. Segreti. 2006. Overview of the epidemiological profile and laboratory detection of extended-spectrum β-lactamases. Clin. Infect. Dis. 42(Suppl. 4):S153-S163.
13. Ramphal, R., and P. G. Ambrose. 2006. Extended-spectrum β-lactamases and clinical outcomes: current data. Clin. Infect. Dis. 42(Suppl. 4):S164-S172.
14. Wheeler, A. P., and G. R. Bernard. 1999. Treating patients with severe sepsis. N. Engl. J. Med. 340:207-215.
15. Winokur, P. L., R. Canton, J. M. Casellas, and N. Legakis. 2001. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32(Suppl. 2):S94-S103.